US Diclofenac Sodium Market to Recover 1.5% in May 2026 After Sharp April Correction

In May ****, the US Diclofenac Sodium market is expected to recover by nearly *.** following the sharp decline recorded in April, supported by improving procurement activity and gradual inventory replenishment across pharmaceutical distribution channels. Market sentiment for Diclofenac Sodium has started to stabilize after aggressive export offers and distributor destocking heavily pressured prices during the previous month. Although Asian supply availability remains ample, buyers are anticipated to return to the market with fresh inquiries, supporting a modest rebound in Diclofenac Sodium prices during May.

During April ****, the US Diclofenac Sodium market faced significant bearish pressure as exporters from India and China maintained strong supply volumes. Heavy cargo arrivals from March created sufficient carry-over inventories at Gulf Coast warehouses, limiting spot buying activity for Diclofenac Sodium throughout the month. In addition, group purchasing organizations renegotiated April–June pharmaceutical contracts with...